Can’t Dissolve Me Now: A COVID-19 Provoked Venous Thromboembolism Breaks Through Apixaban: Case Report

Apixaban for extended treatment of venous thromboembolism.

BACKGROUND Apixaban, an oral factor Xa inhibitor that can be administered in a simple, fixed-dose regimen, may be an option for the extended treatment of venous thromboembolism. METHODS In this randomized, double-blind study, we compared two doses of apixaban (2.5 mg and 5 mg, twice daily) with placebo in patients with venous thromboembolism who had completed 6 to 12 months of anticoagulation...

Recurrent Venous Thromboembolism as the Initial Clinical Presentation of Gastric Cancer: A Case Report

Pulmonary thromboembolism (PTE) is a clinically critical disease, misdiagnosis or delayed diagnosis of which can lead to increased rate of mortality. For prevention of recurrence of PTE, recognition of its risk factors or underlying diseases is of great importance. PTE is common in patients with cancer and has high morbidity and mortality rates. Although cancer is a lethal condition, PTE accele...

Intracerebral and Intraventricular hemorrhage with covid-19: A case report

 Background and Importance: Coronavirus 19 is caused by the SARS-COV-2 virus. The primary target of the virus is the respiratory system, but it can also affect other systems of the body, such as the cardiovascular system and the Central Nervous System )CNS).  Case Presentation: In this study, we introduce an 83-year-old man who referred due to reduced level of consciousness and hemiparesis ...

Covid-19 infection in kidney transplant recipients: a case report

Oral apixaban for the treatment of acute venous thromboembolism.

BACKGROUND Apixaban, an oral factor Xa inhibitor administered in fixed doses, may simplify the treatment of venous thromboembolism. METHODS In this randomized, double-blind study, we compared apixaban (at a dose of 10 mg twice daily for 7 days, followed by 5 mg twice daily for 6 months) with conventional therapy (subcutaneous enoxaparin, followed by warfarin) in 5395 patients with acute venou...